These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24831729)

  • 41. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.
    Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia.
    Campbell-Salome G; Jones LK; Walters NL; Morgan KM; Brangan A; Ladd IG; McGowan MP; Wilemon K; Schmidlen TJ; Simmons E; Schwartz MLB; McMinn MN; Tricou E; Rahm AK; Ahmed CD; Sturm AC
    BMC Health Serv Res; 2023 Apr; 23(1):340. PubMed ID: 37020233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Attitude to genetic screening for familial hypercholesterolemia].
    Ose L; Vollebaek LE; Tonstad S
    Tidsskr Nor Laegeforen; 1998 Apr; 118(10):1578-81. PubMed ID: 9615587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.
    Jones LK; Walters N; Brangan A; Ahmed CD; Gatusky M; Campbell-Salome G; Ladd IG; Sheldon A; Gidding SS; McGowan MP; Rahm AK; Sturm AC
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34205662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NLA Symposium screening and treatment of familial hypercholesterolemia: how can we do better? Opening and introductions.
    McGowan M
    J Clin Lipidol; 2010; 4(5):335-7. PubMed ID: 21122673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention of coronary heart disease in familial hypercholesterolemia].
    Miserez AR; Keller U
    Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical versus molecular diagnosis of heterozygous familial hypercholesterolaemia in the diverse South African population.
    Vergotine J; Thiart R; Kotze MJ
    S Afr Med J; 2001 Dec; 91(12):1053-9. PubMed ID: 11845603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defining the challenges of FH screening for familial hypercholesterolemia.
    Defesche JC
    J Clin Lipidol; 2010; 4(5):338-41. PubMed ID: 21122674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Communication in Families of Children with Familial Hypercholesterolemia: Identifying Motivators and Barriers to Cascade Screening to Improve Diagnosis at a Single Medical Center.
    Wurtmann E; Steinberger J; Veach PM; Khan M; Zierhut H
    J Genet Couns; 2018 Aug; ():. PubMed ID: 30109451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects.
    Pocovi M; Civeira F; Alonso R; Mata P
    Semin Vasc Med; 2004 Feb; 4(1):67-74. PubMed ID: 15199435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
    Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model.
    McGowan MP; Cuchel M; Ahmed CD; Khera A; Weintraub WS; Wilemon KA; Ahmad Z
    Am J Prev Cardiol; 2021 Jun; 6():100170. PubMed ID: 34327496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
    Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan ÜY; Sansoy V
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner.
    Bell DA; Hooper AJ; Edwards G; Southwell L; Pang J; van Bockxmeer FM; Watts GF; Burnett JR
    Atherosclerosis; 2014 Jun; 234(2):469-72. PubMed ID: 24814411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Examining barriers to cascade screening for familial hypercholesterolemia in the United States.
    Andersen R; Andersen L
    J Clin Lipidol; 2016; 10(2):225-7. PubMed ID: 27055953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.